Tobramycin For Cystic Fibrosis Improves Therapeutic Ratio Compared to Parenteral Aminoglycosides
Aerosolised tobramycin’s high sputum concentrations “significantly” improve the therapeutic ratio compared to parenteral aminoglycosides in patients suffering from cystic fibrosis. American researchers – the lead
